IVF NASDAQ
INVO Fertility, Inc.
1W: -10.1%
1M: -37.3%
3M: +43.0%
YTD: +58.9%
1Y: -90.6%
3Y: -99.8%
5Y: -100.0%
$1.43
+0.00 (+0.00%)
Weekly Expected Move ±8.1%
$1
$1
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.0M
52W Range1.41-277.2
Volume55,979
Avg Volume89,228
Beta2.32
Dividend—
Analyst Ratings
Company Info
CEOSteven Shum
Employees30
SectorHealthcare
IndustryMedical - Devices
IPO Date2020-11-02
Websiteinvobioscience.com
5582 Broadcast Court
Sarasota, FL 34240
US
Sarasota, FL 34240
US
978 878 9505
About INVO Fertility, Inc.
INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007 and is headquartered in Sarasota, FL.
Latest News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Trump administration proposes easier employer access to IVF benefits
12 Health Care Stocks Moving In Thursday's Pre-Market Session
INVO Fertility’s Wisconsin Clinic Joins Progyny Network
INVO Fertility (NASDAQ:IVF) and Minerva Surgical (NASDAQ:UTRS) Head-To-Head Analysis
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Krigsvold Terah Rene | 0 | — | 2025-12-30 | |
| Krigsvold Terah Rene | 4,375 | $8.96 | 2025-12-30 | |
| Krigsvold Terah Rene | 11 | $2,119.68 | 2025-12-30 | |
| Krigsvold Terah Rene | 3 | $17,280.00 | 2025-12-30 | |
| Krigsvold Terah Rene | 3 | $17,683.20 | 2025-12-30 |